Immune Response to Genital Papillomavirus Infections in Women Prospects for the Development of a Vaccine against Cervical Cancer
- 1 August 1993
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 690 (1) , 80-85
- https://doi.org/10.1111/j.1749-6632.1993.tb43998.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4Cell, 1992
- Independent association of antibodies against human papillomavirus type 16 and E7 proteins with cervical cancerVirology, 1992
- Antibody response to human papillomavirus (HPV) type 11 in children with juvenile-onset recurrent respiratory papillomatosis (RRP)Virology, 1992
- Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancerVirology, 1992
- Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particlesVirology, 1991
- Human papillomaviruses in the pathogenesis of anogenital cancerVirology, 1991
- Specific interaction between HPV-16 E1–E4 and cytokeratins results in collapse of the epithelial cell intermediate filament networkNature, 1991
- High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3Nature, 1991
- Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7Virology, 1991
- Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen.Proceedings of the National Academy of Sciences, 1991